Pinto Á, Reig O, Iglesias C, Gallardo E, García-Del Muro X, Alonso T, Anguera G, Suárez C, Muñoz-Langa J, Villalobos-León L, Rodríguez-Sánchez Á, Lainez N, Martínez-Ortega E, Campayo M, Velastegui A, Rodriguez-Vida A, Villa-Guzmán JC, Méndez-Vidal MJ, Rubio G, García I, Capdevila L, Lambea J, Vázquez S, Fernández O, Hernando-Polo S, Cerezo S, Santander C, García-Marrero R, Zambrana F, González-Del Alba A, Lazaro-Quintela M, Castellano D, Chirivella I, Anido U, Viana A, García A, Sotelo M, Arévalo MG, García-Donas J, Hernández C, Bolós MV, Llinares J, Climent MA. Clinical Factors Associated With Long-Term Benefit in Patients With Metastatic Renal Cell Carcinoma Treated With Axitinib: Real-World AXILONG Study. Clinical Genitourinary Cancer. 2022; 20(1)DOI:10.1016/j.clgc.2021.09.006. PMID:34789409. IF:3.200(Q2/4D).

Duarte, V, Zaror, C, Villanueva, J, Andreo, M, Dallaserra, M, Salazar, J, Pont, A, Ferrer, M. Oral Health-Related Quality of Life Changes in Patients with Dentofacial Deformities Class II and III after Orthognathic Surgery: A Systematic Review and Meta-Analysis. International Journal of Environmental Research and Public Health. 2022; 19(4)DOI:10.3390/ijerph19041940. PMID:35206128. IF:4.614(Q1/3D).

Cortellini, A, Ricciuti, B, Vaz, VR, Soldato, D, Alessi, JV, Dall'Olio, FG, Banna, GL, Muthuramalingam, S, Chan, S, Majem, M, Piedra, A, Lamberti, G, Andrini, E, Addeo, A, Friedlaender, A, Facchinetti, F, Gorria, T, Mezquita, L, Hoton, D, Valerie, L, Nana, FA, Artingstall, J, Comins, C, Di Maio, M, Caglio, A, Cave, J, McKenzie, H, Newsom-Davis, T, Evans, JS, Tiseo, M, D'Alessio, A, Fulgenzi, CAM, Besse, B, Awad, MM, Pinato, DJ. Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinations. Journal for ImmunoTherapy of Cancer. 2022; 10(2)DOI:10.1136/jitc-2021-004374. PMID:35173031. IF:10.900(Q1/2D).

Dunn, WG, Gu, MXS, Fabre, MA, Cooper, J, Nomdedeu, JF, Koumas, L, Nicolaou, K, Chi, JX, Costeas, P, Vassiliou, GS. The PML-RARA fusion is not detectable in historical blood samples of acute promyelocytic leukaemia patients. ANNALS OF HEMATOLOGY. 2022; 101(2)DOI:10.1007/s00277-021-04472-5. PMID:33650061. IF:3.500(Q2/5D).

Diaz-Riera, E, Garcia-Arguinzonis, M, Lopez, L, Garcia-Moll, X, Badimon, L, Padro, T. Urinary Proteomic Signature in Acute Decompensated Heart Failure: Advances into Molecular Pathophysiology. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(4)DOI:10.3390/ijms23042344. PMID:35216460. IF:5.600(Q1/3D).

Gras-Cabrerizo, JR, Martel-Martin, M, Villatoro-Sologaistoa, JC, De la Torre, FR, Mirapeix, R, Carrera, A, Montserrat-Gili, JR, Pujol-Olmo, A, Massegur-Solench, H. "The Accessory Ethmoidal Canal Does Not Necessarily Contain an Arterial Structure". ENT-EAR NOSE & THROAT JOURNAL. 2022; 101(2_SUPPL)DOI:10.1177/01455613211049656. PMID:34666559. IF:1.300(Q4/9D).

Leon, X, Venegas, MD, Casasayas, M, Rodriguez, C, Neumann, ED, Holgado, A, Quer, M. Prognostic value of the nodal yield in elective neck dissections in patients with head and neck carcinomas. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY. 2022; 279(2)DOI:10.1007/s00405-021-06819-0. PMID:33938992. IF:2.600(Q2/3D).

Martino, R, Garcia-Cadenas, I, Esquirol, A. Daratumumab may be the most effective treatment for post-engraftment pure red cell aplasia due to persistent anti-donor isohemagglutinins after major ABO-mismatched allogeneic transplantation. BONE MARROW TRANSPLANTATION. 2022; 57(2)DOI:10.1038/s41409-021-01507-3. PMID:34711914. IF:4.800(Q1/2D).

Dlouhy, I, Karube, K, Enjuanes, A, Salaverria, I, Nadeu, F, Ramis-Zaldivar, JE, Valero, JG, Rivas-Delgado, A, Magnano, L, Martin-Garcia, D, Perez-Galan, P, Clot, G, Rovira, J, Jares, P, Balague, O, Gine, E, Mozas, P, Briones, J, Sancho, JM, Salar, A, Mercadal, S, Alcoceba, M, Valera, A, Campo, E, Lopez-Guillermo, A. Revised International Prognostic Index and genetic alterations are associated with early failure to R-CHOP in patients with diffuse large B-cell lymphoma. BRITISH JOURNAL OF HAEMATOLOGY. 2022; 196(3)DOI:10.1111/bjh.17858. PMID:34632572. IF:6.500(Q1/3D).

Ribera, J, Granada, I, Morgades, M, Gonzalez, T, Ciudad, J, Such, E, Calasanz, MJ, Mercadal, S, Coll, R, Gonzalez-Campos, J, Tormo, M, Garcia-Cadenas, I, Gil, C, Cervera, M, Barba, P, Costa, D, Ayala, R, Bermudez, A, Orfao, A, Ribera, JM. Prognostic heterogeneity of adult B-cell precursor acute lymphoblastic leukaemia patients with t(1;19)(q23;p13)/ TCF3-PBX1 treated with measurable residual disease-oriented protocols. BRITISH JOURNAL OF HAEMATOLOGY. 2022; 196(3)DOI:10.1111/bjh.17844. PMID:34549416. IF:6.500(Q1/3D).

Allan, JN, Shanafelt, T, Wiestner, A, Moreno, C, O'Brien, SM, Li, JL, Krigsfeld, G, Dean, JP, Ahn, IE. Long-term efficacy of first-line ibrutinib treatment for chronic lymphocytic leukaemia in patients with TP53 aberrations: a pooled analysis from four clinical trials. BRITISH JOURNAL OF HAEMATOLOGY. 2022; 196(4)DOI:10.1111/bjh.17984. PMID:34865212. IF:6.500(Q1/3D).

Rule, S, Barreto, WG, Briones, J, Carella, AM, Casasnovas, O, Pocock, C, Wendtner, CM, Zaja, F, Robson, S, MacGregor, L, Tschopp, RR, Nick, S, Dreyling, M. Efficacy and safety assessment of prolonged maintenance with subcutaneous rituximab in patients with relapsed or refractory indolent non-Hodgkin lymphoma: results of the phase Ill MabCute study. HAEMATOLOGICA. 2022; 107(2)DOI:10.3324/haematol.2020.274803. PMID:34134469. IF:10.100(Q1/2D).

Zvezdanova, ME, Arroyo, MJ, Mendez, G, Candela, A, Mancera, L, Rodriguez, JG, Serra, JL, Jimenez, R, Lozano, I, Castro, C, Lopez, C, Munoz, P, Guinea, J, Escribano, P, Rodriguez-Sanchez, B, Sánchez-Reus F.. Detection of azole resistance in Aspergillus fumigatus complex isolates MALDI-TOF mass. CLINICAL MICROBIOLOGY AND INFECTION. 2022; 28(2)DOI:10.1016/j.cmi.2021.06.005. PMID:34147673. IF:14.200(Q1/1D).

Hueso, M, Grinan, R, Mallen, A, Navarro, E, Purqueras, E, Goma, M, Sbraga, F, Blasco-Lucas, A, Revilla, G, Santos, D, Canyelles, M, Julve, J, Escola-Gil, JC, Rotllan, N. MiR-125b downregulates macrophage scavenger receptor type B1 and reverse cholesterol transport. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2022; 146DOI:10.1016/j.biopha.2021.112596. PMID:35062066. IF:7.500(Q1/1D).

Sampedro, F, Camara, E, Kulisevsky, J. Editorial: Neuroimaging of Cognitive and Neuropsychiatric Symptoms in Movement Disorders. Frontiers in Neurology. 2022; 13DOI:10.3389/fneur.2022.843440. PMID:35173676. IF:3.400(Q2/5D).

Marcucci, M, Painter, TW, Conen, D, Leslie, K, Lomivorotov, VV, Sessler, D, Chan, MTV, Borges, FK, Zapata, MJM, Wang, CY, Xavier, D, Ofori, SN, Landoni, G, Efremov, S, Kleinlugtenbelt, YV, Szczeklik, W, Schmartz, D, Garg, AX, Short, TG, Wittmann, M, Meyhoff, CS, Amir, M, Torres, D, Patel, A, Duceppe, E, Ruetzler, K, Parlow, JL, Tandon, V, Wang, MK, Fleischmann, E, Polanczyk, CA, Jayaram, R, Astrakov, SV, Rao, M, VanHelder, T, Wu, WKK, Cheong, CC, Ayad, S, Abubakirov, M, Kirov, M, Bhatt, K, de Nadal, M, Likhvantsev, V, Iglesisas, PP, Aguado, HJ, McGillion, M, Lamy, A, Whitlock, RP, Roshanov, P, Stillo, D, Copland, I, Vincent, J, Balasubramanian, K, Bangdiwala, SI, Biccard, B, Kurz, A, Srinathan, S, Petit, S, Eikelboom, J, Richards, T, Gross, PL, Alfonsi, P, Guyatt, G, Belley-Cote, E, Spence, J, McIntyre, W, Yusuf, S, Devereaux, PJ. Rationale and design of the PeriOperative ISchemic Evaluation-3 (POISE-3): a randomized controlled trial evaluating tranexamic acid and a strategy to minimize hypotension in noncardiac surgery. Trials. 2022; 23(1)DOI:10.1186/s13063-021-05992-1. PMID:35101083. IF:2.500(Q3/8D).

Blanco-Vaca, F, Rotllan, N, Canyelles, M, Mauricio, D, Escola-Gil, JC, Julve, J. NAD plus -Increasing Strategies to Improve Cardiometabolic Health?. Frontiers in Endocrinology. 2022; 12DOI:10.3389/fendo.2021.815565. PMID:35173682. IF:5.200(Q1/3D).

Jofra, LS, Puig, T, Sola, I, Trujols, J. Interim opioid agonist treatment for opioid addiction: a systematic review. Harm Reduction Journal. 2022; 19(1)DOI:10.1186/s12954-022-00592-x. PMID:35090475. IF:4.400(Q1/2D).

Koller, A, Laughlin, MH, Cenko, E, de Wit, C, Toth, K, Bugiardini, R, Trifunovits, D, Vavlukis, M, Manfrini, O, Lelbach, A, Dornyei, G, Padro, T, Badimon, L, Tousoulis, D, Gielen, S, Duncker, DJ. Functional and structural adaptations of the coronary macro- and microvasculature to regular aerobic exercise by activation of physiological, cellular, and molecular mechanisms: ESC Working Group on Coronary Pathophysiology and Microcirculation position paper. CARDIOVASCULAR RESEARCH. 2022; 118(2)DOI:10.1093/cvr/cvab246. PMID:34358290. IF:10.800(Q1/1D).

Gobom, J, Parnetti, L, Rosa-Neto, P, Vyhnalek, M, Gauthier, S, Cataldi, S, Lerch, O, Laczo, J, Cechova, K, Clarin, M, Benet, AI, Pascoal, TA, Rahmouni, N, Vandijck, M, Huyck, E, Le Bastard, N, Stevenson, J, Chamoun, M, Alcolea, D, Lleo, A, Andreasson, U, Verbeek, MM, Bellomo, G, Rinaldi, R, Ashton, N, Zetterberg, H, Sheardova, K, Hort, J, Blennow, K. Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid. CLINICAL CHEMISTRY AND LABORATORY MEDICINE. 2022; 60(2)DOI:10.1515/cclm-2021-0651. PMID:34773730. IF:6.800(Q1/2D).